15.91
1.73%
-0.28
Pre-mercato:
15.53
-0.38
-2.39%
Precedente Chiudi:
$16.19
Aprire:
$16.32
Volume 24 ore:
186.50K
Relative Volume:
0.53
Capitalizzazione di mercato:
$805.09M
Reddito:
-
Utile/perdita netta:
$-69.13M
Rapporto P/E:
-9.882
EPS:
-1.61
Flusso di cassa netto:
$-50.91M
1 W Prestazione:
-0.19%
1M Prestazione:
+13.64%
6M Prestazione:
-19.36%
1 anno Prestazione:
+21.17%
Tyra Biosciences Inc Stock (TYRA) Company Profile
Nome
Tyra Biosciences Inc
Settore
Industria
Telefono
(619) 728-4760
Indirizzo
2656 STATE STREET, CARLSBAD
Confronta TYRA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
15.91 | 805.09M | 0 | -69.13M | -50.91M | -1.61 |
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-07 | Iniziato | UBS | Buy |
2024-10-18 | Aggiornamento | BofA Securities | Neutral → Buy |
2024-08-15 | Iniziato | Piper Sandler | Overweight |
2023-12-15 | Downgrade | BofA Securities | Buy → Neutral |
2023-06-30 | Iniziato | Wedbush | Outperform |
2023-02-03 | Iniziato | Oppenheimer | Outperform |
2022-06-23 | Iniziato | H.C. Wainwright | Buy |
2022-03-08 | Aggiornamento | Jefferies | Hold → Buy |
2021-11-08 | Downgrade | Jefferies | Buy → Hold |
2021-10-11 | Iniziato | BofA Securities | Buy |
2021-10-11 | Iniziato | Cowen | Outperform |
2021-10-11 | Iniziato | Jefferies | Buy |
Mostra tutto
Tyra Biosciences Inc Borsa (TYRA) Ultime notizie
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 By Investing.com - Investing.com Australia
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 - MSN
Trading (TYRA) With Integrated Risk Controls - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.1%Time to Sell? - MarketBeat
Barclays PLC Has $884,000 Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Trading 7.9% HigherHere's What Happened - MarketBeat
JPMorgan Chase & Co. Has $8.67 Million Stock Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World
Tyra Biosciences' (TYRA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
FDA greenlights phase 2 SURF302 trial of TYRA-300 in NMIBC - Urology Times
Tyra Falls on FDA Nod - Baystreet.ca
Tyra Biosciences advances bladder cancer drug trial - Investing.com
Tyra Biosciences advances bladder cancer drug trial By Investing.com - Investing.com South Africa
Tyra Biosciences Secures FDA Clearance for TYRA-300 Phase 2 Bladder Cancer Trial - StockTitan
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $31.00 Average Target Price from Brokerages - Defense World
UBS Group Initiates Coverage on Tyra Biosciences (NASDAQ:TYRA) - Defense World
Long Term Trading Analysis for (TYRA) - Stock Traders Daily
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Coverage Initiated at UBS Group - MarketBeat
UBS backs Tyra Biosciences stock with long-term growth forecast driven by TYRA-300 pipeline - Investing.com Canada
12,647 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Franklin Resources Inc. - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Stake Lifted by Barclays PLC - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Significant Growth in Short Interest - MarketBeat
(TYRA) Trading Report - Stock Traders Daily
State Street Corp Acquires 16,248 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Head to Head Contrast: Tyra Biosciences (NASDAQ:TYRA) and Checkpoint Therapeutics (NASDAQ:CKPT) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.3%What's Next? - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Wellington Management Group LLP Sells 26,207 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
The Take On Tyra Biosciences (NASDAQ:TYRA) - Seeking Alpha
(TYRA) Trading Signals - Stock Traders Daily
Tyra Biosciences to Present at Upcoming Investor Conferences - The Eastern Progress Online
The Manufacturers Life Insurance Company Invests $333,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Charles Schwab Investment Management Inc. Increases Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
We're Not Very Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Rate - Simply Wall St
Frazier Life Sciences Management L.P. Cuts Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET - Victoria Advocate
Janus Henderson Group PLC Takes Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference - The Eastern Progress Online
Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024) - The Eastern Progress Online
(TYRA) Investment Analysis - Stock Traders Daily
Polar Asset Management Partners Inc. Buys New Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Tyra Biosciences to Participate in 2023 Jefferies London Healthc - GuruFocus.com
Head to Head Survey: Tyra Biosciences (NASDAQ:TYRA) & Wellness Center USA (OTCMKTS:WCUI) - Defense World
Walleye Capital LLC Has $2.98 Million Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Sio Capital Management LLC Has $9.42 Million Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
How to Take Advantage of moves in (TYRA) - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 5%Here's Why - MarketBeat
Short Interest in Tyra Biosciences, Inc. (NASDAQ:TYRA) Drops By 20.0% - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Shares Gap UpWhat's Next? - MarketBeat
RA Capital Management, L.P. Increases Stake in Tyra Biosciences Inc - GuruFocus.com
Tyra Biosciences Inc Azioni (TYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tyra Biosciences Inc Azioni (TYRA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Kjellson Nina S | Director |
Jan 16 '25 |
Sale |
16.29 |
7,779 |
126,697 |
447,857 |
Kjellson Nina S | Director |
Jan 21 '25 |
Sale |
16.36 |
3,993 |
65,336 |
3,707,420 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):